X4 Pharmaceuticals, Inc (XFOR) › Capital ExpendituresX4 Pharmaceuticals, Inc (XFOR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $73.0K2017: $378.0K2018: $02019: $174.0K2020: $1.36M2021: $615.0K2022: $103.0K2023: $60.0K2024: $326.0K2025: $0$02016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$0-100.0%2024$326.0K+443.3%2023$60.0K-41.7%2022$103.0K-83.3%2021$615.0K-54.8%2020$1.36M+682.8%2019$174.0K—2018$0-100.0%2017$378.0K+417.8%2016$73.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share